close 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 74% rachunków inwestorów detalicznych odnotowuje straty w wyniku handlu kontraktami CFD u niniejszego dostawcy. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

888.16

-1.49%↓

JNJ

242.08

+0.61%↑

ABBV

210.85

+0.43%↑

NVS

149.23

-0.83%↓

MRK

120.47

+0.79%↑

LLY

888.16

-1.49%↓

JNJ

242.08

+0.61%↑

ABBV

210.85

+0.43%↑

NVS

149.23

-0.83%↓

MRK

120.47

+0.79%↑

LLY

888.16

-1.49%↓

JNJ

242.08

+0.61%↑

ABBV

210.85

+0.43%↑

NVS

149.23

-0.83%↓

MRK

120.47

+0.79%↑

LLY

888.16

-1.49%↓

JNJ

242.08

+0.61%↑

ABBV

210.85

+0.43%↑

NVS

149.23

-0.83%↓

MRK

120.47

+0.79%↑

LLY

888.16

-1.49%↓

JNJ

242.08

+0.61%↑

ABBV

210.85

+0.43%↑

NVS

149.23

-0.83%↓

MRK

120.47

+0.79%↑

Strona główna・Stock List・Palvella Therapeutics Inc
Search

Palvella Therapeutics Inc

Open

SectorHealthcare

113.06 -2.44

Strong Buy

Price update 27 mar 2026, 16:43 UTC

BuySell

Overview

Share price change

24h

Current

Min

112.01

Max

118.73

Key metrics

By Trading Economics

Income

-1.9M

-11M

Employees

14

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+81.94% upside

Dividends

By Dow Jones

Next Earnings

31 mar 2026

Market Stats

By TradingEconomics

Market Cap

1.4B

Previous open

115.5

Previous close

113.06

News Sentiment

By Acuity

50%

50%

164 / 349 Ranking in Healthcare

Palvella Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

26 mar 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

DJ

Read

26 mar 2026, 23:36 UTC

Market Talk
Major News Events

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

DJ

Read

26 mar 2026, 23:35 UTC

Acquisitions, Mergers, Takeovers

Pernod Ricard: Confirms Discussions With Brown-Forman

DJ

Read

26 mar 2026, 23:29 UTC

Earnings

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

DJ

Read

26 mar 2026, 23:28 UTC

Earnings

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

DJ

Read

26 mar 2026, 23:28 UTC

Earnings

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

DJ

Read

26 mar 2026, 23:28 UTC

Earnings

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

DJ

Read

26 mar 2026, 23:27 UTC

Earnings

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

DJ

Read

26 mar 2026, 23:27 UTC

Earnings

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

DJ

Read

26 mar 2026, 23:08 UTC

Market Talk

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

DJ

Read

26 mar 2026, 23:04 UTC

Acquisitions, Mergers, Takeovers

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

DJ

Read

26 mar 2026, 23:04 UTC

Acquisitions, Mergers, Takeovers

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

DJ

Read

26 mar 2026, 23:04 UTC

Acquisitions, Mergers, Takeovers

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

DJ

Read

26 mar 2026, 23:04 UTC

Acquisitions, Mergers, Takeovers

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

DJ

Read

26 mar 2026, 23:04 UTC

Acquisitions, Mergers, Takeovers

Pernod in Deal Talks With Brown-Forman -- WSJ

DJ

Read

26 mar 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

DJ

Read

26 mar 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

DJ

Read

26 mar 2026, 22:26 UTC

Earnings

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

DJ

Read

26 mar 2026, 22:26 UTC

Earnings

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

DJ

Read

26 mar 2026, 22:26 UTC

Earnings

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

DJ

Read

26 mar 2026, 22:08 UTC

Earnings

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

DJ

Read

26 mar 2026, 22:08 UTC

Earnings

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

DJ

Read

26 mar 2026, 22:08 UTC

Earnings

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

DJ

Read

26 mar 2026, 22:07 UTC

Market Talk
Major News Events

Global Energy Roundup: Market Talk

DJ

Read

26 mar 2026, 22:07 UTC

Market Talk
Major News Events

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

DJ

Read

26 mar 2026, 22:00 UTC

Earnings

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

DJ

Read

26 mar 2026, 22:00 UTC

Earnings

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

DJ

Read

26 mar 2026, 22:00 UTC

Earnings

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

DJ

Read

26 mar 2026, 21:39 UTC

Acquisitions, Mergers, Takeovers

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

DJ

Read

26 mar 2026, 21:38 UTC

Acquisitions, Mergers, Takeovers

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

DJ

Read

Peer Comparison

Price change

Palvella Therapeutics Inc Forecast

Price Target

By TipRanks

81.94% upside

12 Months Forecast

Average 219.04 USD  81.94%

High 270 USD

Low 76.43 USD

Based on 12 Wall Street analysts offering 12 month price targets forPalvella Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

12

Buy

0

Hold

0

Sell

Based on 12 analysts giving stock ratings to Palvella Therapeutics Inc - Dist in the past 3 months.

Sentiment

By Acuity

164 / 349 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

888.16

↓-1.49%

JNJ

Johnson and Johnson

242.08

↑ +0.61%

ABBV

AbbVie Inc

210.85

↑ +0.43%

NVS

Novartis AG

149.23

↓-0.83%

MRK

Merck & Co Inc.

120.47

↑ +0.79%
help-icon Live chat